Company Filing History:
Years Active: 2014
Title: Innovations of Ju Yeon Seo in Stem Cell Research
Introduction
Ju Yeon Seo is an accomplished inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of stem cell research, particularly in the development of culture mediums for mesenchymal stem cells. His innovative work aims to enhance the efficiency and effectiveness of stem cell therapy.
Latest Patents
Ju Yeon Seo holds a patent for a "Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same." This invention relates to a specialized medium for culturing mesenchymal stem cells, which includes a combination of essential components such as basal medium, L-ascorbic acid 2-phosphate, fetal bovine serum, basic fibroblast growth factor (b-FGF), non-essential amino acids (NEAAs), insulin, N-acetyl-L-cysteine, calcium chloride, and hydrocortisone. The method developed allows for the rapid acquisition of mesenchymal stem cells necessary for therapy while improving their differentiation capabilities.
Career Highlights
Ju Yeon Seo is associated with RNL Bio Co., Ltd., a company known for its advancements in biotechnology and regenerative medicine. His work at the company has been pivotal in pushing the boundaries of stem cell applications in medical treatments.
Collaborations
He collaborates with notable colleagues such as Jeong Chan Ra and Sung Keun Kang, who contribute to the research and development efforts in the field of stem cell technology.
Conclusion
Ju Yeon Seo's innovative contributions to stem cell research exemplify the potential of biotechnology in advancing medical therapies. His patented work on culture mediums is a significant step forward in the field, promising improved outcomes for stem cell applications.